Jesse A Columbo1, Ravinder Kang2, Andrew W Hoel3, Jeanwan Kang4, Kathleen A Leinweber5, Karissa S Tauber5, Regis Hila5, Niveditta Ramkumar6, Art Sedrakyan7, Philip P Goodney8. 1. Section of Vascular Surgery, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH; VA Quality Scholars Program, Veterans Health Association, White River Junction, Vt; VA Outcomes Group, Veterans Health Association, White River Junction, Vt; Geisel School of Medicine, Dartmouth College, Hanover, NH; Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Hanover, NH. Electronic address: jesse.a.columbo@hitchcock.org. 2. Section of Vascular Surgery, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH; VA Quality Scholars Program, Veterans Health Association, White River Junction, Vt; VA Outcomes Group, Veterans Health Association, White River Junction, Vt; Geisel School of Medicine, Dartmouth College, Hanover, NH; Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Hanover, NH. 3. Division of Vascular Surgery, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Ill. 4. Section of Vascular Surgery, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Geisel School of Medicine, Dartmouth College, Hanover, NH. 5. Geisel School of Medicine, Dartmouth College, Hanover, NH. 6. Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Hanover, NH. 7. Department of Surgery, Weill Cornell Medical College, New York, NY. 8. Section of Vascular Surgery, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH; VA Outcomes Group, Veterans Health Association, White River Junction, Vt; Geisel School of Medicine, Dartmouth College, Hanover, NH; Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Hanover, NH.
Abstract
OBJECTIVE: The accurate measurement of reintervention after endovascular aneurysm repair (EVAR) is critical during postoperative surveillance. The purpose of this study was to compare reintervention rates after EVAR from three different data sources: the Vascular Quality Initiative (VQI) alone, VQI linked to Medicare claims (VQI-Medicare), and a "gold standard" of clinical chart review supplemented with telephone interviews. METHODS: We reviewed the medical records of 729 patients who underwent EVAR at our institution between 2003 and 2013. We excluded patients without follow-up reported to the VQI (n = 68 [9%]) or without Medicare claims information (n = 114 [16%]). All patients in the final analytic cohort (n = 547) had follow-up information available from all three data sources (VQI alone, VQI linked to Medicare, and chart review). We then compared reintervention rates between the three data sources. Our primary end points were the agreement between the three data sources and the Kaplan-Meier estimated rate of reintervention at 1 year, 2 years, and 3 years after EVAR. For gold standard assessment, we supplemented chart review with telephone interview as necessary to assess reintervention. RESULTS: VQI data alone identified 12 reintervention events in the first year after EVAR. Chart review confirmed all 12 events and identified 18 additional events not captured by the VQI. VQI-Medicare data successfully identified all 30 of these events within the first year. VQI-Medicare also documented four reinterventions in this time period that did not occur on the basis of patient interview (4/547 [0.7%]). The agreement between chart review and VQI-Medicare data at 1 year was excellent (κ = 0.93). At 3 years, there were 81 (18%) reinterventions detected by VQI-Medicare and 70 (16%) detected by chart review for a sensitivity of 92%, specificity of 96%, and κ of 0.80. Kaplan-Meier survival analysis demonstrated similar reintervention rates after 3 years between VQI-Medicare and chart review (log-rank, P = .59). CONCLUSIONS: Chart review after EVAR demonstrated a 6% 1-year and 16% 3-year reintervention rate, and almost all (92%) of these events were accurately captured using VQI-Medicare data. Linking VQI data with Medicare claims allows an accurate assessment of reintervention rates after EVAR without labor-intensive physician chart review. Published by Elsevier Inc.
OBJECTIVE: The accurate measurement of reintervention after endovascular aneurysm repair (EVAR) is critical during postoperative surveillance. The purpose of this study was to compare reintervention rates after EVAR from three different data sources: the Vascular Quality Initiative (VQI) alone, VQI linked to Medicare claims (VQI-Medicare), and a "gold standard" of clinical chart review supplemented with telephone interviews. METHODS: We reviewed the medical records of 729 patients who underwent EVAR at our institution between 2003 and 2013. We excluded patients without follow-up reported to the VQI (n = 68 [9%]) or without Medicare claims information (n = 114 [16%]). All patients in the final analytic cohort (n = 547) had follow-up information available from all three data sources (VQI alone, VQI linked to Medicare, and chart review). We then compared reintervention rates between the three data sources. Our primary end points were the agreement between the three data sources and the Kaplan-Meier estimated rate of reintervention at 1 year, 2 years, and 3 years after EVAR. For gold standard assessment, we supplemented chart review with telephone interview as necessary to assess reintervention. RESULTS: VQI data alone identified 12 reintervention events in the first year after EVAR. Chart review confirmed all 12 events and identified 18 additional events not captured by the VQI. VQI-Medicare data successfully identified all 30 of these events within the first year. VQI-Medicare also documented four reinterventions in this time period that did not occur on the basis of patient interview (4/547 [0.7%]). The agreement between chart review and VQI-Medicare data at 1 year was excellent (κ = 0.93). At 3 years, there were 81 (18%) reinterventions detected by VQI-Medicare and 70 (16%) detected by chart review for a sensitivity of 92%, specificity of 96%, and κ of 0.80. Kaplan-Meier survival analysis demonstrated similar reintervention rates after 3 years between VQI-Medicare and chart review (log-rank, P = .59). CONCLUSIONS: Chart review after EVAR demonstrated a 6% 1-year and 16% 3-year reintervention rate, and almost all (92%) of these events were accurately captured using VQI-Medicare data. Linking VQI data with Medicare claims allows an accurate assessment of reintervention rates after EVAR without labor-intensive physician chart review. Published by Elsevier Inc.
Authors: Neetu Chawla; K Robin Yabroff; Angela Mariotto; Timothy S McNeel; Deborah Schrag; Joan L Warren Journal: Ann Epidemiol Date: 2014-07-03 Impact factor: 3.797
Authors: Andres Schanzer; Louis M Messina; Kaushik Ghosh; Jessica P Simons; William P Robinson; Francesco A Aiello; Robert J Goldberg; Allison B Rosen Journal: J Vasc Surg Date: 2014-11-01 Impact factor: 4.268
Authors: Marc L Schermerhorn; Dominique B Buck; A James O'Malley; Thomas Curran; John C McCallum; Jeremy Darling; Bruce E Landon Journal: N Engl J Med Date: 2015-07-23 Impact factor: 91.245
Authors: Rodney P Bensley; Shunsuke Yoshida; Ruby C Lo; Margriet Fokkema; Allen D Hamdan; Mark C Wyers; Elliot L Chaikof; Marc L Schermerhorn Journal: J Vasc Surg Date: 2013-03-13 Impact factor: 4.268
Authors: Sharath Chandra Vikram Paravastu; Rubaraj Jayarajasingam; Rachel Cottam; Simon J Palfreyman; Jonathan A Michaels; Steven M Thomas Journal: Cochrane Database Syst Rev Date: 2014-01-23
Authors: Jesse A Columbo; Art Sedrakyan; Jialin Mao; Andrew W Hoel; Spencer W Trooboff; Ravinder Kang; Jeremiah R Brown; Philip P Goodney Journal: J Vasc Surg Date: 2019-03-25 Impact factor: 4.268
Authors: Dominique Vervoort; Joseph K Canner; Elliott R Haut; James H Black; Christopher J Abularrage; Devin S Zarkowsky; James C Iannuzzi; Caitlin W Hicks Journal: J Surg Res Date: 2021-08-14 Impact factor: 2.192
Authors: Jialin Mao; Kayla O Moore; Jesse A Columbo; Kunal S Mehta; Philip P Goodney; Art Sedrakyan Journal: J Vasc Surg Date: 2022-02-15 Impact factor: 4.860
Authors: Jesse A Columbo; Niveditta Ramkumar; Pablo Martinez-Camblor; Ravinder Kang; Bjoern D Suckow; A James O'Malley; Art Sedrakyan; Philip P Goodney Journal: J Vasc Surg Date: 2019-08-27 Impact factor: 4.268
Authors: Georg Apfaltrer; Francesco Lavra; U Joseph Schoepf; Marco Scarabello; Ricardo Yamada; Marly van Assen; Akos Varga-Szemes; Brian E Jacobs; Maximilian J Bauer; William T Greenberg; Marcelo Guimaraes; Luca Saba; Carlo N De Cecco Journal: PLoS One Date: 2021-01-07 Impact factor: 3.240
Authors: Xavier Philip Fowler; Barbara Gladders; Kayla Moore; Jialin Mao; Art Sedrakyan; Philip Goodney Journal: BMJ Surg Interv Health Technol Date: 2022-10-07
Authors: Zachary J Wanken; Peter B Anderson; Sarah Y Bessen; John B Rode; Jesse A Columbo; Spencer W Trooboff; Kayla O Moore; Philip P Goodney Journal: J Vasc Surg Date: 2020-02-17 Impact factor: 4.268
Authors: Spencer W Trooboff; Zachary J Wanken; Barbara Gladders; Jesse A Columbo; Jon D Lurie; Philip P Goodney Journal: Circ Cardiovasc Qual Outcomes Date: 2020-05-07